Solicitation Amendment 80JSC026Q00140002 SF 30.pdf
PDF 101 KB Posted
- Attached to
- Venous Thrombosis (VT)
- Solicitation number
- 80JSC026Q0014
About this file
This is Amendment 0002 to Solicitation 80JSC026Q0014, issued by NASA Johnson Space Center on September 28, 2026. The amendment corrects a spelling error in Contract Line Item Number (CLIN) 0001 from "Venus Thrombosis" to "Venous Thrombosis" and extends the period of performance end date from September 30, 2030 to September 30, 2031. The solicitation pertains to Venous Thrombosis (VT) approach(es) to surveil, reduce risk of, and/or prevent/treat VT during spaceflight and exploration missions, including rationale and methodology, as detailed in the referenced Performance Work Statement (PWS).
Offerors must acknowledge receipt of this amendment prior to the specified hour and date by completing items 8 and 15 and returning the form, acknowledging receipt on each copy of the offer submitted, or submitting a separate letter or electronic communication referencing the solicitation and amendment numbers. The contracting officer is Katelyn Jaime (katelyn.r.jaime@nasa.gov), and the contract specialist is Brenda C. Huerta (brenda.c.huerta@nasa.gov). The amended period of performance for CLIN 0001 runs from January 7, 2027 to September 30, 2031. Accounting and appropriation data can be found in Section G of the solicitation.
View the file
Other files
Show all 12
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:
(a) By completing items 8 and 15, and returning or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE
RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.
E. IMPORTANT: Contractor is not is required to sign this document and return copies to the issuing office.
AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT
1. CONTRACT ID CODE
2. AMENDMENT/MODIFICATION NUMBER 3. EFFECTIVE DATE 4. REQUISITION/PURCHASE REQUISITION NUMBER 5. PROJECT NUMBER (If applicable)
7. ADMINISTERED BY (If other than Item 6) CODE
STANDARD FORM 30 (REV. 11/2016)
Prescribed by GSA FAR (48 CFR) 53.243
FACILITY CODE
9A. AMENDMENT OF SOLICITATION NUMBER
9B. DATED (SEE ITEM 11)
10A. MODIFICATION OF CONTRACT/ORDER NUMBER
10B. DATED (SEE ITEM 13)
11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers is extended. is not extended.
12. ACCOUNTING AND APPROPRIATION DATA (If required) copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted;
13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.
IT MODIFIES THE CONTRACT/ORDER NUMBER AS DESCRIBED IN ITEM 14.
CHECK ONE A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER
NUMBER IN ITEM 10A.
B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).
C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:
D. OTHER (Specify type of modification and authority)
Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.
15C. DATE SIGNED
15A. NAME AND TITLE OF SIGNER (Type or print)
16C. DATE SIGNED
16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)
14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)
PAGE OF PAGES
6. ISSUED BY CODE
8. NAME AND ADDRESS OF CONTRACTOR (Number, street, county, State and ZIP Code) (X)
CODE
15B. CONTRACTOR/OFFEROR
(Signature of person authorized to sign)
16B. UNITED STATES OF AMERICA
(Signature of Contracting Officer)
Previous edition unusable
SECTION SF 30 BLOCK 14 CONTINUATION PAGE
SUMMARY OF CHANGES
Purpose of this amendment is to:
Correct spelling error on CLIN 0001 from "Venus" to "Venous".
Correct period of performance end date from 2030 to 2031.
Section B - Supplies or Services & Prices or Costs
The following CLIN(s) / SLIN(s) were modified:
0001 -
Venous Thrombosis (VT) approach(es) to surveil, reduce risk of, and/or prevent/treat (either prophylactic or treatment countermeasures) VT during spaceflight and exploration missions, including rationale and methodology.
Please Reference the Performance Work Statement (PWS).
INFORMATION FROM TO
Description
Venus Thrombosis (VT) approach(es) to surveil, reduce risk of, and/or prevent/treat (either prophylactic or treatment countermeasures) VT during spaceflight and exploration missions, including rationale and methodology.
Please Reference the Performance Work Statement
(PWS).
Venous Thrombosis (VT) approach(es) to surveil, reduce risk of, and/or prevent/treat (either prophylactic or treatment countermeasures) VT during spaceflight and exploration missions, including rationale and methodology.
Please Reference the Performance Work Statement
(PWS).
Section C - Specification/SOW/SOO/ORD
The Requirements text has been modified to:
Venous Thrombosis (VT)
80JSC026Q00140002
Section F - Deliveries or Performance
The delivery information for the following CLIN(s) / SLIN(s) were modified:
0001 -
Venous Thrombosis (VT) approach(es) to surveil, reduce risk of, and/or prevent/treat (either prophylactic or treatment countermeasures) VT during spaceflight and exploration missions, including rationale and methodology.
Please Reference the Performance Work Statement (PWS).
INFORMATION FROM TO
Period of Performance 01/07/2027 to 09/30/2030 01/07/2027 to 09/30/2031
80JSC026Q00140002
| 1_01_IDCode_Text: |
| 1_01_Page_Text: 1 |
| 1_01_Pages_Text: 3 |
| 1_02_AmendNo_Text: 0002 |
| 1_03_EffDate_Text: 9/28/2026 |
| 1_01_ReqNo_Text: |
| 1_05_ProjNo_Text: |
| 1_06_IssuedBy_Text: NASA JOHNSON SPACE CENTER |
2101 NASA Parkway
HOUSTON, TX 77058-3696
United States Huerta, Brenda C. (JSC-AH712), Contract Specialist, Email: brenda.c.huerta@nasa.gov
| 1_03_IssCode_Text: 80JSC0 |
| 1_07_AdminBy_Text: |
| 1_01_AdmCode_Text: |
| 1_08_ContractorNameAdd_Text: |
| 1_08_Code_Text: |
| 1_08_FacCode_Text: |
| 1_08_SolChg_CheckBox: 1 |
| 1_09B_SolDate_Text: 9/28/2026 |
| 1_09A_SolNo_Text: 80JSC026Q0014 |
| 1_10A_AwardNo_Text: |
| 1_10B_AwardDate_Text: |
| 1_11_Amended_CheckBox: 1 |
| 1_11_OffrExt_CheckBox: |
| 1_11_NoCopies_Text: 1 |
| 1_12_ApprData_Text: See Section G |
| 1_13_ChgeOrd_CheckBox: |
| 1_13_Modify_CheckBox: |
| 1_13_SuppAgre_CheckBox: |
| 1_13E_Copies_Text: |
| 1_14_Descript_Text: SEE CONTINUATION PAGE |
| 1_15A_ContNameTitle_Text: |
| 1_15C_ContDate_Text: |
| 1_16A_CoNameTitle_Text: Katelyn Jaime |
Email: katelyn.r.jaime@nasa.gov
| 1_10_AwardChg_Checkox: |
| 1_16C_DateSignedCOEsig_Text: |
| 1_13E_NoReq_Checkox: |
| 1_13E_Require_Checkox: |
| 1_11_OffrNoEx_Checkbox: 1 |
| 1_13_ModOthr_Checkbbox: |
| 1_13C_SuppAuth_Text: |
| 1_13D_OthrSpec_Text: |
| 1_13A_ChgeOrder_Text: |
| 1_16B_COSignature_Text: |
File details come from the government source that posted it. Updated .